C4 therapeutics to present at bank of america securities precision oncology conference 2022

Watertown, mass., sept. 26, 2022 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that c4t management will participate in a fireside chat at the virtual bank of america securities precision oncology conference 2022.
CCCC Ratings Summary
CCCC Quant Ranking